Skip to Main Content

Paper Details

Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
Lab Invest
57
2016
-catenin, /, ATP, AXIN2, Ascites cells, PORCN, R-spondin 2, RSPO, RSPO fusion transcripts, RSPO fusions, RSPO2, RSPO3, WLS, WNT974, WNT974100M, Wnt, ascites, ascites cells, carboplatin, ovarian cancer, papillary serous ovarian cancer, patient, patients, porcupine, primary, primary ovarian cancer, primary ovarian cancer ascites cells, trypan blue, tumor, untreated cells
Author NameAffiliation
Sara J CooperHudsonAlpha Institute for Biotechnology
William E GrizzleUniversity of Alabama at Birmingham
Gerald McGwinUniversity of Alabama at Birmingham
  • 1 - 3

Datasets

Release 1.2